Sabra Healthcare REIT (NASDAQ:SBRA) Releases FY 2025 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.455-1.465 for the period, compared to the consensus earnings per share estimate of 1.060. The company issued revenue guidance of -.

Sabra Healthcare REIT Price Performance

Shares of SBRA traded up $0.65 during mid-day trading on Thursday, hitting $18.85. 5,926,615 shares of the stock were exchanged, compared to its average volume of 2,524,497. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The company has a market cap of $4.52 billion, a PE ratio of 24.80, a price-to-earnings-growth ratio of 1.10 and a beta of 0.84. Sabra Healthcare REIT has a 52-week low of $15.60 and a 52-week high of $20.03. The firm has a 50-day moving average of $18.42 and a two-hundred day moving average of $18.25.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. During the same period last year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, equities analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Monday, November 17th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. The ex-dividend date of this dividend is Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 157.89%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on SBRA shares. Wells Fargo & Company cut their target price on Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Truist Financial boosted their price objective on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price target on the stock. Finally, National Bankshares set a $22.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, October 17th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and an average price target of $20.75.

Institutional Investors Weigh In On Sabra Healthcare REIT

Large investors have recently added to or reduced their stakes in the stock. Osaic Holdings Inc. grew its stake in Sabra Healthcare REIT by 4.6% in the 2nd quarter. Osaic Holdings Inc. now owns 25,925 shares of the real estate investment trust’s stock worth $478,000 after acquiring an additional 1,137 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the period. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Sabra Healthcare REIT by 0.6% in the second quarter. CANADA LIFE ASSURANCE Co now owns 273,952 shares of the real estate investment trust’s stock valued at $5,058,000 after purchasing an additional 1,710 shares during the period. Focus Partners Wealth grew its stake in Sabra Healthcare REIT by 11.4% in the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after purchasing an additional 2,557 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.